{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:45:43Z","timestamp":1793857543521,"version":"4.6.1"},"reference-count":40,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"unspecified","delay-in-days":47,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2025,7,30]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The primary objective was to assess the prevalence of anti-ribosomal-P protein antibodies (anti-Rib-P) in a well-characterised Danish adult SLE cohort. Secondary objectives included (1) assessing any association between anti-Rib-P and neuropsychiatric SLE (NPSLE), (2) assessing any association between anti-Rib-P and characteristics of Danish patients with SLE and (3) assessing potential associations between selected autoantibodies and NPSLE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This cross-sectional study included 198 Danish patients with SLE from a population-based cohort. Patients meet the American College of Rheumatology\u2019s 1997 revised classification criteria for SLE and were 18 years of age or older. Anti-Rib-P were detected in serum using fluorescence enzyme immunoassay. ANA patterns were tested using indirect immunofluorescence on HEp-2 cells. Anti-double-stranded DNA antibody was examined by manual ELISA, and antibodies targeting Ro\/SSA, La\/SSB, Sm, RNP, Scl-70, Jo-1, Centromer B and Histone were examined on a Luminex instrument.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 14 (7.1%) patients with anti-Rib-P positive SLE, and 3 anti-Rib-P positive patients were diagnosed with NPSLE (21% of patients with NPSLE). There was no statistically significant association between anti-Rib-P and NPSLE. The mean anti-Rib-P titres in the patients with NPSLE did not differ significantly from patients without NPSLE patients\u2019 titres. We observed a significant association between anti-Rib-P positivity and disease activity measured by the SLEDAI-2K (SLE Disease Activity Index 2000) score. A stepwise logistic regression found an association between NPSLE and SLEDAI-2K and SLICC DI (SLE International Collaborating Clinics Damage Index) score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study could not confirm a role for anti-Rib-P in the identification of NPSLE. On the other hand, anti-Rib-P was associated with SLE disease activity as well as organ damage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2025-001550","type":"journal-article","created":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T22:20:27Z","timestamp":1755469227000},"page":"e001550","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Anti-ribosomal-P protein antibodies and systemic lupus erythematosus (SLE): in a cross-sectional study of Danish adult patients with SLE, no significant association is found between anti-ribosomal-P and neuropsychiatric SLE"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1571-0290","authenticated-orcid":false,"given":"Sabine Lerke","family":"Kamstrup","sequence":"first","affiliation":[{"name":"Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark"},{"name":"Department of Rheumatology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4858-2156","authenticated-orcid":false,"given":"Nanna Surlemont","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Danish Centre for Expertise in Rheumatology (CeViG), Danish Hospital for Rheumatic Diseases, Sonderborg, Denmark"},{"name":"Thrombosis and Haemostasis, Guy's and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3700-0755","authenticated-orcid":false,"given":"Henrik Zachar","family":"Langkilde","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Odense University Hospital, Odense, Denmark"},{"name":"Department of Clinical Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7885-8400","authenticated-orcid":false,"given":"Anna Christine","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark"},{"name":"Department of Clinical Immunology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6582-2636","authenticated-orcid":false,"given":"Anne","family":"Voss","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Odense University Hospital, Odense, Denmark"},{"name":"Department of Clinical Research, University of Southern Denmark Faculty of Health Sciences, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,17]]},"reference":[{"key":"2026010700552996000_12.2.e001550.1","doi-asserted-by":"publisher","DOI":"10.1080\/03009740802419073"},{"key":"2026010700552996000_12.2.e001550.2","doi-asserted-by":"crossref","first-page":"v29","DOI":"10.1093\/rheumatology\/keaa382","article-title":"Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors","volume":"59","author":"Arnaud","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2026010700552996000_12.2.e001550.3","doi-asserted-by":"crossref","unstructured":"Elefante E , Tani C , Stagnaro C , et al . n.d. Self-Reported Anxiety and Depression in a Monocentric Cohort of Patients With Systemic Lupus Erythematosus: Analysis of Prevalence, Main Determinants, and Impact on Quality of Life. Front Med 9:859840. doi:10.3389\/fmed.2022.859840","DOI":"10.3389\/fmed.2022.859840"},{"key":"2026010700552996000_12.2.e001550.4","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F"},{"key":"2026010700552996000_12.2.e001550.5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/14397595.2018.1508801","article-title":"Anti-ribosomal P protein antibodies influence mortality of patients with diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematous involving a severe form of the disease","volume":"29","author":"Arinuma","year":"2019","journal-title":"Mod Rheumatol"},{"key":"2026010700552996000_12.2.e001550.6","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12020192","article-title":"Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Literature Review of the Last Decade","volume":"12","author":"Lindblom","year":"2022","journal-title":"Brain Sci"},{"key":"2026010700552996000_12.2.e001550.7","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.39"},{"key":"2026010700552996000_12.2.e001550.8","doi-asserted-by":"crossref","unstructured":"Pisetsky DS . The central role of nucleic acids in the pathogenesis of systemic lupus erythematosus. F1000Res 2019;8. doi:10.12688\/f1000research.17959.1","DOI":"10.12688\/f1000research.17959.1"},{"key":"2026010700552996000_12.2.e001550.9","first-page":"723","article-title":"Autoantibodies persist in relatives to systemic lupus erythematosus patients during 12 years follow-up","volume":"26","author":"Langkilde","year":"2017","journal-title":"Lupus (Los Angel)"},{"key":"2026010700552996000_12.2.e001550.10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.162.2.459"},{"key":"2026010700552996000_12.2.e001550.11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.19.7419"},{"key":"2026010700552996000_12.2.e001550.12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/08916930400022699","article-title":"Anti-ribosomal P protein antibodies","volume":"38","author":"Gerli","year":"2005","journal-title":"Autoimmunity"},{"key":"2026010700552996000_12.2.e001550.13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071285"},{"key":"2026010700552996000_12.2.e001550.14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000260"},{"key":"2026010700552996000_12.2.e001550.15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/art.38900","article-title":"Anti-ribosomal P protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice","volume":"67","author":"Bravo-Zehnder","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2026010700552996000_12.2.e001550.16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep142"},{"key":"2026010700552996000_12.2.e001550.17","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020192","article-title":"Study on the correlation between anti-ribosomal P protein antibody and systemic lupus erythematosus","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"2026010700552996000_12.2.e001550.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2008.12.002"},{"key":"2026010700552996000_12.2.e001550.19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.12.1357"},{"key":"2026010700552996000_12.2.e001550.20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jalm\/jfab045","article-title":"Association of Antiribosomal P Antibody with Neurological and Systemic Manifestations in Patients with Systemic Lupus Erythematosus in Southwestern Colombia","volume":"7","author":"Mar\u00edn","year":"2022","journal-title":"J Appl Lab Med"},{"key":"2026010700552996000_12.2.e001550.21","article-title":"Clinical Features and Outcomes of Neuropsychiatric Systemic Lupus Erythematosus in China","volume":"2021","author":"Zhang","year":"2021","journal-title":"J Immunol Res"},{"key":"2026010700552996000_12.2.e001550.22","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780290806"},{"key":"2026010700552996000_12.2.e001550.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198707303170503"},{"key":"2026010700552996000_12.2.e001550.24","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90506-S"},{"key":"2026010700552996000_12.2.e001550.25","first-page":"178","article-title":"Neuropsychiatric manifestations in patients with systemic lupus erythematosus: diagnostic and predictive value of longitudinal examination of anti-ribosomal P antibody","volume":"5","author":"Watanabe","year":"1996","journal-title":"Lupus (Los Angel)"},{"key":"2026010700552996000_12.2.e001550.26","doi-asserted-by":"crossref","first-page":"102463","DOI":"10.1016\/j.autrev.2020.102463","article-title":"A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus","volume":"19","author":"Choi","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2026010700552996000_12.2.e001550.27","first-page":"588","article-title":"The association of serum anti-ribosomal P antibody with clinical and serological disorders in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"24","author":"Shi","year":"2015","journal-title":"Lupus (Los Angel)"},{"key":"2026010700552996000_12.2.e001550.28","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2019.12.44","article-title":"Expression of HMGB1 and TLR4 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders","volume":"8","author":"Huang","year":"2020","journal-title":"Ann Transl Med"},{"key":"2026010700552996000_12.2.e001550.29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1352458517699791","article-title":"Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: A predominantly population-based study","volume":"24","author":"Asgari","year":"2018","journal-title":"Mult Scler"},{"key":"2026010700552996000_12.2.e001550.30","doi-asserted-by":"publisher","DOI":"10.1080\/030097498440958"},{"key":"2026010700552996000_12.2.e001550.31","first-page":"v","article-title":"Systemic lupus erythematosus: a clinical analysis","volume":"6","author":"Fries","year":"1975","journal-title":"Major Probl Intern Med"},{"key":"2026010700552996000_12.2.e001550.32","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"2026010700552996000_12.2.e001550.33","first-page":"219","article-title":"A damage index for lupus patients--where are we now?","volume":"6","author":"Stoll","year":"1997","journal-title":"Lupus (Los Angel)"},{"key":"2026010700552996000_12.2.e001550.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2026010700552996000_12.2.e001550.35","article-title":"Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects","volume":"2014","author":"Cozzani","year":"2014","journal-title":"Autoimmune Dis"},{"key":"2026010700552996000_12.2.e001550.36","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/rheumatology\/keae134","article-title":"Anti-histone and anti-nucleosome rather than anti-dsDNA antibodies associate with IFN-induced biomarkers in Sudanese and Swedish SLE patients","volume":"64","author":"Elbagir","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026010700552996000_12.2.e001550.37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1157149","article-title":"Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"14","author":"Cocco","year":"2023","journal-title":"Front Immunol"},{"key":"2026010700552996000_12.2.e001550.38","first-page":"860","article-title":"Anti-ribosomal P antibodies related to depression in early clinical course of systemic lupus erythematosus","volume":"18","author":"Karimifar","year":"2013","journal-title":"J Res Med Sci"},{"key":"2026010700552996000_12.2.e001550.39","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-008-0921-1"},{"key":"2026010700552996000_12.2.e001550.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.11.014"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2025-001550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:55:54Z","timestamp":1767776154000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2025-001550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8,17]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/lupus-2025-001550"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2025-001550","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}